NO20072831L - Imidazo[1,2-A]Pyridinforbindelser, sammensetninger, anvendelser og fremgangsmater relatert dertil - Google Patents

Imidazo[1,2-A]Pyridinforbindelser, sammensetninger, anvendelser og fremgangsmater relatert dertil

Info

Publication number: NO20072831L
Authority: NO; Norway
Prior art keywords: imidazo; compositions; pyridine compounds; methods related; compounds
Prior art date: 2004-11-11

Application number

NO20072831A

Other languages

English (en)

Norwegian (no)

Inventor

Albert Palomer

Antonio Guglietta

Jose Luis Falco

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-11

Filing date

2007-06-04

Publication date

2007-08-01

2007-06-04 Application filed by Ferrer Int filed Critical Ferrer Int

2007-08-01 Publication of NO20072831L publication Critical patent/NO20072831L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20072831A 2004-11-11 2007-06-04 Imidazo[1,2-A]Pyridinforbindelser, sammensetninger, anvendelser og fremgangsmater relatert dertil NO20072831L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04105698		2004-11-11
PCT/EP2005/055753 WO2006051063A1 (en)	2004-11-11	2005-11-04	Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto

Publications (1)

Publication Number	Publication Date
NO20072831L true NO20072831L (no)	2007-08-01

Family

ID=34929843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072831A NO20072831L (no)	2004-11-11	2007-06-04	Imidazo[1,2-A]Pyridinforbindelser, sammensetninger, anvendelser og fremgangsmater relatert dertil

Country Status (24)

Country	Link
US (1)	US20080200473A1 (da)
EP (1)	EP1814880B1 (da)
JP (1)	JP2008519805A (da)
KR (1)	KR20070084026A (da)
CN (1)	CN101065377B (da)
AR (1)	AR051626A1 (da)
AT (1)	ATE421962T1 (da)
AU (1)	AU2005303811A1 (da)
BR (1)	BRPI0517796A (da)
CA (1)	CA2585315A1 (da)
DE (1)	DE602005012598D1 (da)
DK (1)	DK1814880T3 (da)
ES (1)	ES2321858T3 (da)
IL (1)	IL182963A0 (da)
MX (1)	MX2007005611A (da)
NO (1)	NO20072831L (da)
PA (1)	PA8652101A1 (da)
PE (1)	PE20060967A1 (da)
PL (1)	PL1814880T3 (da)
PT (1)	PT1814880E (da)
RU (1)	RU2007121864A (da)
TW (1)	TWI357412B (da)
UY (1)	UY29204A1 (da)
WO (1)	WO2006051063A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2477604A1 (en)	2002-03-13	2003-09-25	Signum Biosciences, Inc.	Modulation of protein methylation and phosphoprotein phosphate
EP1843734A4 (en)	2005-02-03	2008-09-10	Signum Biosciences Inc	COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION
US7923041B2 (en)	2005-02-03	2011-04-12	Signum Biosciences, Inc.	Compositions and methods for enhancing cognitive function
EP1845098A1 (en) *	2006-03-29	2007-10-17	Ferrer Internacional, S.A.	Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
CA2651857A1 (en) *	2006-05-31	2007-12-06	F. Hoffmann-La Roche Ag	Aryl-4-ethynyl-isoxazole derivatives
WO2008022396A1 (en) *	2006-08-24	2008-02-28	Australian Nuclear Science & Technology Organisation	Fluorinated ligands for targeting peripheral benzodiazepine receptors
WO2009132051A1 (en)	2008-04-21	2009-10-29	Signum Biosciences, Inc.	Compounds, compositions and methods for making the same
AU2009249186B2 (en) *	2008-05-19	2014-05-22	Sunovion Pharmaceuticals Inc.	Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators
WO2010045615A2 (en)	2008-10-16	2010-04-22	Cenomed Biosciences, Llc	Treatment of organophosphate exposure with ocinaplon
US20120010188A1 (en) *	2008-12-04	2012-01-12	Promimagen Ltd.	Imidazopyridine Compounds
US9309238B2 (en) *	2009-11-05	2016-04-12	University Of Notre Dame Du Lac	Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same
EP2617715A4 (en) *	2010-09-17	2014-02-26	Taisho Pharmaceutical Co Ltd	GLYCINTRANSPORTERHEMMER
BR112018005208B1 (pt)	2015-09-17	2023-12-12	Marvin J. Miller	Compostos heterocíclicos que contêm benzilamina e composições úteis contra infecção micobacteriana
CN106906486B (zh) *	2017-02-22	2018-12-11	华南理工大学	3-溴-2-苯基-咪唑并[1,2-α]吡啶类衍生物的电化学合成方法
EP4096668A4 (en) *	2020-01-29	2024-02-28	Foghorn Therapeutics Inc.	Compounds and uses thereof
CN118515663A (zh) *	2023-04-24	2024-08-20	上海赛默罗生物科技有限公司	咪唑并吡啶或咪唑并吡嗪类化合物、其制备方法、药物组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2568880B1 (fr) *	1984-08-07	1986-12-12	Synthelabo	Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2593818B1 (fr) *	1986-02-05	1988-04-29	Synthelabo	Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2593181B1 (fr) *	1986-01-22	1988-04-01	Synthelabo	Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
EP0234970B1 (fr) *	1986-01-22	1991-04-17	Synthelabo	Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
WO2004066930A2 (en) *	2003-01-27	2004-08-12	Arthur Zaks	Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives

2005
- 2005-11-04 WO PCT/EP2005/055753 patent/WO2006051063A1/en active Application Filing
- 2005-11-04 MX MX2007005611A patent/MX2007005611A/es active IP Right Grant
- 2005-11-04 ES ES05808135T patent/ES2321858T3/es active Active
- 2005-11-04 DE DE602005012598T patent/DE602005012598D1/de active Active
- 2005-11-04 CN CN2005800386913A patent/CN101065377B/zh not_active Expired - Fee Related
- 2005-11-04 DK DK05808135T patent/DK1814880T3/da active
- 2005-11-04 BR BRPI0517796-0A patent/BRPI0517796A/pt not_active IP Right Cessation
- 2005-11-04 JP JP2007540634A patent/JP2008519805A/ja active Pending
- 2005-11-04 RU RU2007121864/04A patent/RU2007121864A/ru not_active Application Discontinuation
- 2005-11-04 KR KR1020077010318A patent/KR20070084026A/ko not_active Application Discontinuation
- 2005-11-04 AT AT05808135T patent/ATE421962T1/de active
- 2005-11-04 US US11/667,494 patent/US20080200473A1/en not_active Abandoned
- 2005-11-04 CA CA002585315A patent/CA2585315A1/en not_active Abandoned
- 2005-11-04 PL PL05808135T patent/PL1814880T3/pl unknown
- 2005-11-04 PT PT05808135T patent/PT1814880E/pt unknown
- 2005-11-04 EP EP05808135A patent/EP1814880B1/en not_active Not-in-force
- 2005-11-04 AU AU2005303811A patent/AU2005303811A1/en not_active Abandoned
- 2005-11-07 PE PE2005001302A patent/PE20060967A1/es not_active Application Discontinuation
- 2005-11-08 PA PA20058652101A patent/PA8652101A1/es unknown
- 2005-11-08 TW TW094139042A patent/TWI357412B/zh not_active IP Right Cessation
- 2005-11-09 AR ARP050104693A patent/AR051626A1/es not_active Application Discontinuation
- 2005-11-10 UY UY29204A patent/UY29204A1/es not_active Application Discontinuation
2007
- 2007-05-03 IL IL182963A patent/IL182963A0/en unknown
- 2007-06-04 NO NO20072831A patent/NO20072831L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TWI357412B (en)	2012-02-01
PA8652101A1 (es)	2006-10-13
BRPI0517796A (pt)	2008-10-28
CA2585315A1 (en)	2006-05-18
RU2007121864A (ru)	2008-12-20
PT1814880E (pt)	2009-04-23
KR20070084026A (ko)	2007-08-24
PL1814880T3 (pl)	2009-07-31
WO2006051063A1 (en)	2006-05-18
DE602005012598D1 (de)	2009-03-19
MX2007005611A (es)	2007-07-11
ES2321858T3 (es)	2009-06-12
PE20060967A1 (es)	2006-09-20
EP1814880A1 (en)	2007-08-08
UY29204A1 (es)	2006-01-31
US20080200473A1 (en)	2008-08-21
TW200624432A (en)	2006-07-16
CN101065377A (zh)	2007-10-31
EP1814880B1 (en)	2009-01-28
AR051626A1 (es)	2007-01-24
DK1814880T3 (da)	2009-05-18
AU2005303811A1 (en)	2006-05-18
IL182963A0 (en)	2007-08-19
JP2008519805A (ja)	2008-06-12
ATE421962T1 (de)	2009-02-15
CN101065377B (zh)	2011-07-27

Publication	Publication Date	Title
NO20072831L (no)	2007-08-01	Imidazo[1,2-A]Pyridinforbindelser, sammensetninger, anvendelser og fremgangsmater relatert dertil
NO20084129L (no)	2008-10-29	Pyridin(3,4-B)Pyrazinoner
NO20066055L (no)	2007-01-24	Pyridinderivater
EA201000615A1 (ru)	2010-12-30	Производные имидазо[1,2-а]пиридина, применимые в качестве ингибиторов апк (активиноподобной киназы)
TW200728307A (en)	2007-08-01	Novel spirochromanone derivatives
NO20050417L (no)	2005-02-17	Azaindol kinase-inhibitorer
NO20062139L (no)	2006-07-21	Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
WO2006124490A3 (en)	2007-03-08	Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2007120647A3 (en)	2007-11-29	Compositions useful as inhibitors of voltage-gated sodium channels
WO2005123703A8 (en)	2007-02-15	Alkynyl derivatives as modulators of metabotropic glutamate receptors
NO20062692L (no)	2006-08-14	Heterosykliske MEK inhibitorer og fremgangsmater for anvendelse derav
NO20044882L (no)	2004-11-09	Acyl-4-karboksylfenylurinstoffderivater, deres fremstilling og anvendelse
NO20076659L (no)	2008-03-18	Pyrrolo(2,3-B)pyridinderivater som protein kinase inhibitorer
WO2007095223A3 (en)	2010-06-24	Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
MX2009004096A (es)	2009-06-16	Metabolitos de talarozol.
NO20083427L (no)	2008-10-14	Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20085066L (no)	2009-02-06	4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20054208L (no)	2005-09-09	Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
UA90706C2 (ru)	2010-05-25	Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
NO20082136L (no)	2008-06-30	1,5-substituerte indol-2-yl-amidderivater
WO2006067614A3 (en)	2007-01-04	Heteroaromatic derivatives useful as anticancer agents
NO20054852L (no)	2005-12-13	GFAT inhibitorer
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
EP1637521A4 (en)	2009-08-26	NEW TRICYCLIC HETEROCYCLIC COMPOUND
UA83875C2 (ru)	2008-08-26	Производные хинолина для применения в качестве микобактериальных ингибиторов

Legal Events

Date	Code	Title	Description
2013-06-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application